Rationale and Design of the SYNTAX II Trial Evaluating the Short to Long-Term Outcomes of State-Of-The-Art Percutaneous Coronary Revascularisation in Patients With De Novo Three-Vessel Disease

EuroIntervention - France
doi 10.4244/eijv12i2a36

Related search